Seenthis
•
 
Identifiants personnels
  • [mot de passe oublié ?]

 

unagi

@unagi
//
RSS: unagi
tous les messages de unagi
  • @unagi
    unagi @unagi CC BY-NC 22/09/2021
    11
    @simplicissimus
    @mad_meg
    @7h36
    @odilon
    @colporteur
    @kassem
    @fil
    @rastapopoulos
    @02myseenthis01
    @biggrizzly
    @pix_wave
    11

    New report shows leading Covid-19 vaccine pharma companies fuelling unprecedented human rights crisis | Amnesty International
    ▻https://www.amnesty.org/en/latest/news/2021/09/new-report-shows-leading-covid-19-vaccine-pharma-companies-fuelling-unprece

    https://www.amnesty.org/en/wp-content/uploads/2021/09/278794-scaled.jpg

    Six companies at the helm of the Covid-19 vaccine roll-out are fuelling an unprecedented human rights crisis through their refusal to waive intellectual property rights and share vaccine technology, with most failing to prioritise vaccine deliveries to poorer countries, Amnesty International said today.

    In a new report, A Double Dose of Inequality: Pharma companies and the Covid-19 vaccines crisis, the organization assessed six of the companies that hold the fate of billions of people in their hands: AstraZeneca plc, BioNTech SE, Johnson & Johnson, Moderna, Inc., Novavax, Inc. and Pfizer, Inc. It paints a dismal picture of an industry that is woefully failing to respect human rights.

    “Vaccinating the world is our only pathway out of this crisis. It should be time to hail these companies, who created vaccines so quickly, as heroes. But instead, to their shame and our collective grief, Big Pharma’s intentional blocking of knowledge transfer and their wheeling and dealing in favor of wealthy states has brewed an utterly predictable and utterly devastating vaccine scarcity for so many others” said Agnès Callamard, Amnesty International’s Secretary General.

    “Its plunging parts of Latin America, Africa and Asia into renewed crises, pushing weakened health systems to the very brink and causing tens of thousands of preventable deaths every week. In many low-income countries not even health workers and people at-risk have received the vaccine.”

    “Against the backdrop of these gross inequalities BioNTech, Moderna and Pfizer are set to make US$130 billion combined by the end of 2022. Profits should never come before lives.”

    unagi @unagi CC BY-NC
    • @simplicissimus
      Simplicissimus @simplicissimus 22/09/2021

      Une double dose d’inégalité : Les laboratoires pharmaceutiques et la crise des vaccins contre le COVID-19 (Sommaire)
      ▻https://www.amnesty.org/en/documents/pol40/4621/2021/fr

      La mise au point rapide de vaccins efficaces contre le COVID-19 en 2020 a donné de l’espoir au monde aux heures les plus sombres de la pandémie mortelle qu’il traverse. Cependant, ce sont les pays riches qui ont massivement bénéficié de leur déploiement. Ce rapport se concentre sur six des plus grands laboratoires ayant mis au point des vaccins. Il évalue leurs politiques d’entreprise en matière de droits humains, leur structure tarifaire, leurs archives relatives à la propriété intellectuelle et au partage des savoir-faire et des technologies, leur politique de distribution des doses de vaccin disponibles et la transparence de leurs opérations.

      lien vers le rapport en français (entre autres)

      Simplicissimus @simplicissimus
    • @unagi
      unagi @unagi CC BY-NC 22/09/2021

      C’est ballot...
      Vaccins contre le COVID-19. Un nouveau rapport montre que les laboratoires pharmaceutiques alimentent une crise des droits humains sans précédent | Amnesty International
      ▻https://www.amnesty.org/fr/latest/news/2021/09/new-report-shows-leading-covid-19-vaccine-pharma-companies-fuelling-unprece

      https://www.amnesty.org/fr/wp-content/uploads/sites/8/2021/09/278794-scaled.jpg

      unagi @unagi CC BY-NC
    • @kassem
      Kassem @kassem CC BY-NC-SA 22/09/2021

      #profits #l’important

      Kassem @kassem CC BY-NC-SA
    Écrire un commentaire
À propos de Seenthis Propriété intellectuelle Recommandations API